- Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products
- This expansion aims to meet the various needs and interests of patients seeking effective and convenient medical cannabis options
- Medical cannabis pastilles offer several key benefits, including easy oral intake and prolonged effects that provide long-lasting relief after digestion
- Aurora Cannabis stock (TSX:ACB) last traded at C$8.30
Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products.
This expansion aims to meet the various needs and interests of patients seeking effective and convenient medical cannabis options.
Medical cannabis pastilles offer several key benefits, including easy oral intake and prolonged effects that provide long-lasting relief after digestion. These pastilles are also available in a discrete, portable, and convenient format, making them accessible for patients on the go.
The newly available pastilles in Australia include:
- Aurora Pastilles – 10mg THC Pomegranate Berry (30 pack)
- Aurora Pastilles – 10:10 Balanced Pineapple (30 pack)
- Aurora Pastilles – 25mg CBD Acai Berry (30 pack)
Aurora continues to maintain its position as the largest global medical cannabis company operating in nationally legal markets. The company has a product pipeline planned for global introduction over the coming months.
“Expanding our portfolio of medical cannabis pastilles in Australia demonstrates our understanding of market demand and is another example of our ability to bring high quality product to this key market as patient interest increases,” Andre Jerome, Aurora’s executive vice president of global business development said in a news release. “In this rapidly expanding market, we’re leveraging our unique capabilities, including global manufacturing and excellence in navigating regulatory frameworks that define Aurora’s leadership.”
Aurora is a global cannabis company serving both the medical and consumer markets across Canada, Europe, Australia and South America. Its brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being, Greybeard, MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co., Pedanios, IndiMed and CraftPlant.
Aurora Cannabis stock (TSX:ACB) last traded at C$8.30 and has grown 89.07 per cent since this time last year.
Join the discussion: Find out what everybody’s saying about this cannabis stock’s expansion in Germany on the Aurora Cannabis Inc. Bullboard and check out Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top photo of an Aurora Cannabis grow room: Aurora Cannabis)
